The profile is largely consistent with the established GLP-1 RA class, characterized primarily by manageable gastrointestinal side effects, but also includes specific warnings and precautions that require careful clinical attention and patient counseling
Semaglutide and cardiovascular outcomes in patients with obesity and established cardiovascular disease (SELECT trial)
As a versatile treatment option, fillers can be injected practically anywhere on the body to tighten and rejuvenate the skin
9 Great Breakfasts for People Using GLP-1 Weight Loss Medications If youre taking a GLP-1 weight loss drug like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), or orforglipron (Foundayo), you may find yourself feeling less hungry in the morning
Many people quit taking GLP-1s due to high costs and lack of insurance coverage, especially for obesity